ARCHIVES

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

This article is from The Cancer Letter archive.

Vol. 37 No. 40 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

July 25, 2014

Capitol Hill: Mammography Quality standards Act Reintroduced

April 18, 1997

Gene Therapy Hyped By Scientists, Panel Tells NIH; Emphasis Must Be Basic Research

December 15, 1995

Amazon Links To NCI Materials, A First For NIH Health Content.

July 14, 2000

FDA Approves Molecular Test For Breast Cancer Detection

July 27, 2007

RFA On Breast Tumor Factors Patients Survival

June 20, 1980